Furthermore since the endotoxin specification change was implemented, the TB Antigen and Nil tubes were manufactured without process validation and released, "FDA said."

Exosomes released by dendritic cells are enriched in antigen-presenting molecules, they are stable in physical properties, easy to preserve, and can be manufactured rapidly.